Professor Paul Turner
Infectious diseases are prevalent in Cambodia, a country that is struggling with poor infrastructure. Streptococcus pneumoniae causes the most severe form of pneumonia and is now targeted by the pneumococcal conjugate vaccine. Dr Paul Turner is studying the effect of this vaccine in field conditions in SE Asia, as well as other direct applications such as the evaluation of a new diagnostic test for Typhoid and interventions to reduce the burden of infections acquired within hospitals.
MB BS, PhD, FRCPCH, FRCPath
- Senior Clinical Research Fellow
- Consultant in Microbiology
- Director of the Cambodia Oxford Medical Research Unit
Clinical microbiologist with a focus on paediatric infections
Paul Turner is based at the Cambodia-Oxford Medical Research Unit (COMRU), Angkor Hospital for Children in Siem Reap, Cambodia.
His research interests include:
- Antimicrobial resistance surveillance and control;
- Paediatric healthcare associated infections;
- Pneumococcal colonisation and disease and the impact of pneumococcal vaccines;
- Utilisation of bacterial colonisation data.
His non-research work focuses on development of human and laboratory capacity for diagnostic microbiology in low-resource settings.
Mai TT. et al, (2021), BMC Bioinformatics, 22
Chung The H. et al, (2021), Communications Biology, 4
Ling CL. et al, (2021), BMC Infectious Diseases, 21
Turner P. et al, (2021), The Lancet. Infectious diseases
Chandna A. et al, (2021), Emerg Infect Dis, 27, 1169 - 1172